Difference between revisions of "Rectal cancer"
Jump to navigation
Jump to search
(Copied from MRI of rectal cancer) |
Rhcastilhos (talk | contribs) |
||
| Line 1: | Line 1: | ||
{{Top | {{Top | ||
| − | |author1=[[User:Rhcastilhos|Rodrigo | + | |author1=[[User:Rhcastilhos|Rodrigo Castilhos]] |
|author2=Authors of integrated Creative Commons article<ref name="Beets-TanLambregts2017">{{cite journal|last1=Beets-Tan|first1=Regina G. H.|last2=Lambregts|first2=Doenja M. J.|last3=Maas|first3=Monique|last4=Bipat|first4=Shandra|last5=Barbaro|first5=Brunella|last6=Curvo-Semedo|first6=Luís|last7=Fenlon|first7=Helen M.|last8=Gollub|first8=Marc J.|last9=Gourtsoyianni|first9=Sofia|last10=Halligan|first10=Steve|last11=Hoeffel|first11=Christine|last12=Kim|first12=Seung Ho|last13=Laghi|first13=Andrea|last14=Maier|first14=Andrea|last15=Rafaelsen|first15=Søren R.|last16=Stoker|first16=Jaap|last17=Taylor|first17=Stuart A.|last18=Torkzad|first18=Michael R.|last19=Blomqvist|first19=Lennart|title=Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting|journal=European Radiology|volume=28|issue=4|year=2017|pages=1465–1475|issn=0938-7994|doi=10.1007/s00330-017-5026-2}}</ref> | |author2=Authors of integrated Creative Commons article<ref name="Beets-TanLambregts2017">{{cite journal|last1=Beets-Tan|first1=Regina G. H.|last2=Lambregts|first2=Doenja M. J.|last3=Maas|first3=Monique|last4=Bipat|first4=Shandra|last5=Barbaro|first5=Brunella|last6=Curvo-Semedo|first6=Luís|last7=Fenlon|first7=Helen M.|last8=Gollub|first8=Marc J.|last9=Gourtsoyianni|first9=Sofia|last10=Halligan|first10=Steve|last11=Hoeffel|first11=Christine|last12=Kim|first12=Seung Ho|last13=Laghi|first13=Andrea|last14=Maier|first14=Andrea|last15=Rafaelsen|first15=Søren R.|last16=Stoker|first16=Jaap|last17=Taylor|first17=Stuart A.|last18=Torkzad|first18=Michael R.|last19=Blomqvist|first19=Lennart|title=Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting|journal=European Radiology|volume=28|issue=4|year=2017|pages=1465–1475|issn=0938-7994|doi=10.1007/s00330-017-5026-2}}</ref> | ||
}} | }} | ||
Latest revision as of 01:42, 31 October 2020
Authors:
Rodrigo Castilhos; Authors of integrated Creative Commons article[1] [notes 1]
Planning
Choice of modality
- MRI of rectal cancer is generally mandatory for both primary staging and restaging of a known rectal cancer.[1]
- Endorectal ultrasound (EUS) is indicated for:[1]
- Staging for early tumours considered for local excision
- Superior diagnostic performance for differentiating T1 from T2 tumors
Notes
- ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Radlines:Authorship for details.
References
- ↑ 1.0 1.1 1.2 Beets-Tan, Regina G. H.; Lambregts, Doenja M. J.; Maas, Monique; Bipat, Shandra; Barbaro, Brunella; Curvo-Semedo, Luís; Fenlon, Helen M.; Gollub, Marc J.; et al. (2017). "Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting ". European Radiology 28 (4): 1465–1475. doi:. ISSN 0938-7994.
